Showing results (31-40 of 48) with videos related to
Sort By:
Pageof 5
Journal of Medical Economics|April 11, 2014
Indirect and non-medical economic burden, quality-of-life, and disabilities of the myelofibrosis disease in SpainEmmanuel Gimenez, Carles Besses, Concepcion Boque, et al.Annals of Hematology|January 29, 2013
Clinical evaluation of the European LeukemiaNet response criteria in patients with essential thrombocythemia treated with anagrelideJuan Carlos Hernández-Boluda, Arturo Pereira, Francisco Cervantes, et al.Plos One|January 4, 2013
Study of regulatory T-cells in patients with gastric malt lymphoma: influence on treatment response and outcomeMar García, Beatriz Bellosillo, Blanca Sánchez-González, et al.Cancer Genomics & Proteomics|December 30, 2016
MicroRNAs 142-3p, miR-155 and miR-203 Are Deregulated in Gastric MALT Lymphomas Compared to Chronic GastritisConcepción Fernández, Beatriz Bellosillo, Mariana Ferraro, et al.European Journal of Haematology|May 22, 2015
Risk factors for non-melanoma skin cancer in patients with essential thrombocythemia and polycythemia veraMontse Gómez, Vicent Guillem, Arturo Pereira, et al.Genes|October 27, 2022
Identification of Two Novel EPOR Gene Variants in Primary Familial Polycythemia: Case Report and Literature ReviewLaura Lo Riso, Gardenia Vargas-Parra, Gemma Navarro, et al.Blood|April 13, 2012
A polymorphism in the XPD gene predisposes to leukemic transformation and new nonmyeloid malignancies in essential thrombocythemia and polycythemia veraJuan-Carlos Hernández-Boluda, Arturo Pereira, Francisco Cervantes, et al.Blood|December 14, 2011
Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia veraAlberto Alvarez-Larrán, Arturo Pereira, Francisco Cervantes, et al.Haematologica|May 30, 2013
Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasmsCristina Pérez, Marien Pascual, José Ignacio Martín-Subero, et al.Haematologica|January 19, 2019
Epigenomic profiling of myelofibrosis reveals widespread DNA methylation changes in enhancer elements and ZFP36L1 as a potential tumor suppressor gene that is epigenetically regulatedNicolás Martínez-Calle, Marien Pascual, Raquel Ordoñez, et al.Pageof 5